February 21, 2018 / 5:55 PM / 8 months ago

BRIEF-Glenmark Pharma Enters Exclusive Collaboration Agreement with SCD Pharmaceuticals

Feb 21 (Reuters) - Glenmark Pharmaceuticals Ltd:

* GLENMARK PHARMACEUTICALS - ‍ENTERED INTO EXCLUSIVE DEAL WITH SAM CHUN DANG PHARM

* GLENMARK PHARMACEUTICALS SAYS PRODUCTS FROM AGREEMENT WILL BE DEVELOPED AND MANUFACTURED BY SCD IN SOUTH KOREA

* GLENMARK PHARMACEUTICALS SAYS WILL SEEK ALL MARKET AUTHORIZATIONS AND COMMERCIALIZE PRODUCTS FROM AGREEMENT IN NORTH AMERICA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below